This website uses cookies

Read our Privacy policy and Terms of use for more information.

Known for their use in weight management and Type 2 diabetes, GLP-1s are now being assessed for their potential in improving symptoms of PMOS. New research from Nova Southeastern University found connections between GLP-1 use by patients with PMOS and improved menstrual regularity, ovulation rates and pregnancy rates during IVF treatment. However, larger randomized trials are necessary before these effects are conclusively connected.